Try our Advanced Search for more refined results
8,465,765
Orally effective methylphenidate extended release powder and aqueous suspension product
- July 07, 2022 Actavis Loss In ADHD Drug IP Fight Backed By Fed. Circ.
- April 08, 2021 Teva Unit Urges Fed Circ. To Revive ADHD Drug Row
- December 01, 2020 Del. Judge Finds Teva Infringed ADHD Drug IP On Remand
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
View all the results
Already a subscriber? Click here to login